Monday December 01 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

 
Syngene Appoints PerkinElmer as Canadian Distributor Guarantees Premier Service for Image Analyser Customers
July 22 2003 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce that it has appointed PerkinElmer Life Sciences, one of the world’s largest life science supply companies as its exclusive distributor in Canada.

Under the terms of the agreement, PerkinElmer has sole rights to market Syngene’s unique range of fluorescent and chemiluminescent image analysis and documentation equipment in Canada. This includes the powerful GeneGenius fluorescent image analyser and multi-award winning GeneGnome, the world’s only dedicated chemiluminescence system. For their part, Syngene will provide comprehensive technical service and training to ensure PerkinElmer’s scientific sales professionals can expertly market and support Syngene’s image analysers.

Glenn Carnegie, Central Branch Manager for PerkinElmer Life Sciences Canada stated: “To offer a total proteomics solution we had to have versatile image analysers in our product portfolio, which would perfectly complement our leading imaging instruments. After assessing a number of analysers, we concluded Syngene provides just that with their feature packed high quality systems. When the opportunity arose to be their Canadian distributor, we were keen to enter into an agreement and we are now looking forward to a very productive working relationship.”

Paul Ellwood, Syngene’s Sales and Marketing Director added: “We are delighted to have a company of PerkinElmer’s calibre to be our Canadian distributor. The fact such a major supplier approached us is a bonus and a great endorsement of the well-deserved reputation for excellence our analysers now enjoy internationally. We decided to partner with PerkinElmer because only a company of their scientific standing can provide the professional approach to ensure Canadian users of Syngene image analysis systems will receive the highest standard of sales and service care.”

-Ends- 

For Further Information Contact:
Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44 (0) 1223-727123 Fax +44 (0) 1223-727101
Email: jayne.arthur@syngene.com  Web site: www.syngene.com  

Glenn Carnegie, PerkinElmer Life Sciences Canada, 501 Rowntree Dairy Road, 
Unit #6, Woodbridge, Ontario L4L 8H1, Canada.
Tel: + 905 673 8028 Ext. 223 Fax: + 905 851 1814
Email: glenn.carnegie@perkinelmer.com  Web site: www.perkinelmer.com 

Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax + 44 (0) 1462- 635327 Email: sue6.pearson@ntlworld.com 

Note to Editors

About Syngene
Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes. 

Syngene, founded in 1997 is a division of the Cambridge based Synoptics Group. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 50 people in its UK and subsidiary operation in Frederick, USA. The Group has profitable revenue of almost $10 million and continues to grow rapidly.

About PerkinElmer Life Sciences
PerkinElmer Life Sciences is a global provider of drug discovery, research, and genetic disease screening solutions for customers in a variety of businesses. 
Incorporating Packard®, NEN®, and Wallac™ product brands, PerkinElmer Life Sciences offers a complete line of instrumentation, reagents and consumables, as well as assay development, sample preparation and biochip technologies for the academic, biotechnology, clinical and pharmaceutical industries. 

PerkinElmer Life Sciences is one of three strategic business units of PerkinElmer, Inc., (NYSE: PKI), a global technology leader focused in Life Sciences, Optoelectronics and Analytical Instruments. The Company operates in more than 125 countries, and is a component of the S&P 500 Index. 

Additional information is available through www.perkinelmer.com  or 1-877-PKI-NYSE.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.